MaxCyte, Inc. (LON:MXCT – Get Free Report) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 322.33 ($4.18) and traded as low as GBX 242 ($3.14). MaxCyte shares last traded at GBX 243.10 ($3.15), with a volume of 9,254 shares changing hands.
MaxCyte Trading Down 1.2 %
The company has a debt-to-equity ratio of 8.59, a current ratio of 9.81 and a quick ratio of 14.38. The stock has a market cap of £320.90 million, a price-to-earnings ratio of -8.91 and a beta of 1.13. The company’s fifty day moving average price is GBX 322.33 and its 200-day moving average price is GBX 307.30.
About MaxCyte
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients.
See Also
- Five stocks we like better than MaxCyte
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How Technical Indicators Can Help You Find Oversold Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Market Cap Calculator: How to Calculate Market Cap
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
